Dr. David S. Schulman, MD

Dr. Schulman practices at Glendora Digestive Disease Institute in Glendora, California.

Dr. Schulman's NPI, 1548365216, was assigned on September 14, 2006. Dr. Schulman graduated from Albert Einstein College of Medicine in 1984. Dr. Schulman holds California license G60526.

Dr. Schulman's primary practice is Glendora Digestive Disease Institute, at 1794 S Barranca Avenue, Glendora, CA 91740. The practice phone is (626) 858-4600.

Dr. Schulman's primary practice is Glendora Digestive Disease Institute in Glendora, California. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Schulman to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schulman practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Schulman's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Schulman is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Schulman's licenses on file in 2 states: California and Virginia.

CMS data shows 15 Medicare services from Dr. Schulman across 1 procedure code in 2024, for 36 Medicare patients. Medicare paid $3,267 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 36 Medicare patients who saw Dr. Schulman in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 0.85, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schulman's median patient age at 60, with 53% women.

In 2024, Dr. Schulman wrote 31 Medicare Part D claims for 17 patients. 77% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $185 in total drug cost. In 2022, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Schulman for performance year 2024, reported as part of a group. Dr. Schulman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 293 general payments to Dr. Schulman from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 57% of the total. Gilead Sciences, Inc. paid the most, $7,194.

Dmand AI lists 1 award for Dr. Schulman, most recently CMS Stage 1 EHR in 2013.

Dr. Schulman graduated from Albert Einstein College of Medicine in 1984. Dr. Schulman is a member of ACP.

Dr. Schulman is in network with 9 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Kaiser Permanente. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.